NCT07493447 2026-03-25Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical ProceduresVanderbilt-Ingram Cancer CenterPhase EARLY_PHASE1 Not yet recruiting30 enrolled